Quote:
Originally Posted by 'Hamas' Jenkins
Close. Tocilizumab.
Here's the key: all monoclonal antibodies will end with -mab (Monoclonal AntiBody)
If it is derived from a mouse (murIne) or is a chImera, it will be -imab
If it is derived from a hUman, it will be -umab.
|
Yep. We just published an article on a novel glycoengineered mAb for MS.
Another drug we work on-- a kinase inhibitor (-inib), not the mAb-- is being tested for treatment of COVID-19 as it has shown some strong properties to calm the cytokine storm/complement activation.